Andrographolide Inhibits Cholangiocarcinoma Cell Migration by Down-Regulation of Claudin-1 via the p-38 Signaling PathwayPhorutai Pearngam, Tavan Janvilisri|Frontiers in Pharmacology|2019Cited by 32
Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validationChawalit Ngernsombat, Tavan Janvilisri|Scientific Reports|2024Cited by 5